Enhanced rapid tests for perinatal group B streptococci (GBS) diagnosis in pregnant women and their babies. The AmpliSens project addresses the development of a rapid and portable molecular test for the screen-out of neonatal sepsis caused by GBS in the blood or cerebrospinal fluid of the newborn, as well as for the screening of pregnant women. The product developed by the project, AmpliFast, relies on two modules: a battery-operated hand-held thermocycler to perform double-tagging end-point PCR in combination with a rapid diagnostic test platform consisting of a reader and a disposable cartridge. The diagnostic test is rapid and [...]
